Yves Horsmans

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Medicine, Internal Medicine, Pharmacology +8

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 466 citations

Medicine, Internal Medicine, Pharmacotherapy +12

HLA association of amoxicillin-clavulanate–induced hepatitis

M. Hautekèete, Yves Horsmans, C. Van Waeyenberge et al. · Gastroenterology · 1999 · 284 citations · Full text

Medicine, Immunology, Pharmacology +14

Curcumin inhibits NF-κB activation and reduces the severity of experimental steatohepatitis in mice

Isabelle Leclercq, Geoffrey C. Farrell, Christine Sempoux et al. · Journal of Hepatology · 2004 · 220 citations

Veterinary Medicine, Pathobiology, Pharmacology +14

A Pilot Study of Therapeutic Vaccination With Envelope Protein E1 in 35 Patients With Chronic Hepatitis C

Frederik Nevens, Tania Roskams, Hans Van Vlierberghe et al. · Hepatology · 2003 · 133 citations

Veterinary Medicine, Immunology, Infectious Diseases +17